Archives
-
Matrine as a Causal Probe in Cancer Biology
2026-09-30
Matrine is an anticancer alkaloid that can be studied beyond simple viability loss. This evidence-weighted guide connects thymoma stemness, apoptosis, YTHDF1–Wnt/β-catenin signaling, and cross-model validation to help researchers design more informative assays.
-
ω-Agatoxin IVA TFA: Cav2.1 Assay Guide
2026-09-29
ω-Agatoxin IVA TFA enables selective Cav2.1 inhibition for neuronal calcium current recording, synaptic transmission research, and epilepsy models. Its value is greatest when P-type and Q-type responses, NP-motif sensitivity, and weak N-type cross-reactivity are handled as distinct experimental variables.
-
Azithromycin Workflows for Resistance Research
2026-09-29
Translate Azithromycin’s ribosome-targeting activity into reproducible susceptibility, degradation-control, and resistance-surveillance workflows. The approach also shows where culture screens, genotype-informed MIC testing, and carefully separated animal-model evidence can add value.
-
Maridomycin: In Vitro and In Vivo Antibacterial Activity
2026-09-28
The reference study established maridomycin as a macrolide with substantial activity against Gram-positive organisms and selected Gram-negative bacteria, while systematically examining pH, inoculum, serum, resistance, bactericidal behavior, and efficacy in infected mice. Its comparison with leucomycin, now commonly called kitasamycin, provides a useful historical framework for antibacterial drug discovery and macrolide resistance characterization.
-
YAP–TEAD Super-Enhancers in Surface Ectoderm
2026-09-28
This study maps super-enhancer activity during pluripotent stem cell differentiation toward surface ectoderm and uses targeted perturbations to connect regulatory elements with gene expression. Its findings identify YAP–TEAD activity as an accelerator of early super-enhancer establishment and ectoderm commitment, while highlighting the value of combining 3D genome information with functional tests.
-
Verteporfin: Separating Phototoxicity from Senolysis
2026-09-27
Verteporfin (CL 318952) can help researchers probe light-dependent cell injury and light-independent autophagy effects, but neither alone establishes senolytic activity. This article connects Verteporfin assay design with machine-learning senolytic research and shows how to distinguish selective senescent-cell clearance from general toxicity.
-
3-Aminobenzamide: Reading PARP Inhibition in Context
2026-09-26
3-Aminobenzamide (PARP-IN-1) is a useful probe for studying PARP-linked stress responses, but its meaning depends on the model and readout. This article connects antiviral host-restriction findings with practical assay design and the limits of broad pharmacological inhibition.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-09-25
Hao et al. developed a glutathione-responsive metal-organic framework nanoparticle that combines indocyanine green photothermal therapy with delivery of the PD-1/PD-L1 blocking peptide AUNP12. The study provides a materials-design strategy for pairing local heat-induced tumor damage with checkpoint inhibition, while also highlighting the need to validate release, immune activation, and therapeutic benefit as separate steps.
-
SIRT4–GDH Control of Glutamine Metabolism in Fibrosis
2026-09-25
The study identifies reduced SIRT4 activity and increased GDH-linked glutamine catabolism as features that support hepatic stellate cell activation and liver fibrosis. Cellular and animal experiments indicate that inhibiting GDH or restoring SIRT4 can restrain this metabolic pathway, providing a mechanistic rationale for further antifibrotic research.
-
L-Phenylephrine as a Baroreflex Probe in AngII Models
2026-09-24
L-Phenylephrine is an adrenergic α1A receptor agonist that can help researchers examine how vascular pressor input is translated into reflex heart-rate control. This article interprets a sex-aware angiotensin II mouse study as an assay-design problem, clarifying what phenylephrine challenges reveal—and what they cannot localize.
-
Brassinolide: From Plant Biology to Translational Insight
2026-09-24
Brassinolide connects plant growth regulation with emerging preclinical research in apoptosis and metabolic models. Recent brassinosteroid structure–activity findings also show why assay selection matters—and how translational teams can build more disciplined, reproducible studies.
-
Antipyrine in BBB Permeability Workflows
2026-09-23
Use Antipyrine as a practical small-molecule comparator when developing permeability and pharmacokinetic workflows, while keeping its analgesic and antipyretic research applications distinct from BBB readouts. A recent LLC-PK1-MDR1 study shows how barrier integrity, transporter efflux, and compound recovery can be evaluated together—and why recovery checks matter as much as permeability.
-
Cyclic di-GMP, Genome Stability, and Biofilm Persistence
2026-09-23
Liao and colleagues identify a biofilm-associated toxin–antitoxin-like system in which the toxin HipH damages bacterial DNA, while cyclic di-GMP functions as a small-molecule antitoxin. Their findings connect adhesion-stage signaling to genome instability and antibiotic persistence, showing that persister enrichment can begin before a mature biofilm structure develops.
-
Polybrene and the Translational p53 Delivery Stack
2026-09-22
A mechanistic and strategic guide to using Polybrene to improve delivery control when investigating mutant p53 reactivation and chemically induced proximity.
-
Temporal Transcriptomics Maps Host Targets Against EBOV
2026-09-22
This preprint integrates time-series transcriptomics, network inference, host–virus interaction data, RNA interference, and drug screening to identify host programs that change across Ebola virus infection. Its prioritization of RELB, LDLR, MYC, Sorafenib, and Thioguanine provides a useful framework for host-directed antiviral research, while the findings require validation because the study has not yet undergone peer review.